Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00IDR
|
||||
Former ID |
DIB007096
|
||||
Drug Name |
Phenylalanine hydroxylase
|
||||
Synonyms |
Oralase; Phenylase; AvPAL-PEG; PEG-PAL; Phenylalanine hydroxylase, BioMarin; Phenylalanine hydroxylase, IBEX; Poly ethylene glycol-phenylalanine ammonia lyase; RAvPAL-PEG; Phenylketonuria therapy (enzyme), BioMarin
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Phase 2 | [522703] | ||
Company |
Biomarin pharmaceutical
|
||||
CAS Number |
CAS 9029-73-6
|
||||
Target and Pathway | |||||
Target(s) | Phenylalanine hydroxylase | Target Info | Modulator | [532742] | |
BioCyc Pathway | Phenylalanine degradation/tyrosine biosynthesis | ||||
PathWhiz Pathway | Phenylalanine and Tyrosine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.